相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor
Damayanthi Devineni et al.
CLINICAL THERAPEUTICS (2015)
Treatment With the Dipeptidyl Peptidase-4 Inhibitor Linagliptin or Placebo Followed by Glimepiride in Patients With Type 2 Diabetes With Moderate to Severe Renal Impairment: A 52-Week, Randomized, Double-Blind Clinical Trial
Markku Laakso et al.
DIABETES CARE (2015)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY - CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN-2015
Yehuda Handelsman et al.
ENDOCRINE PRACTICE (2015)
Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025
Alexander Kainz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi et al.
DIABETES CARE (2015)
AACE Comprehensive Diabetes Management Algorithm 2013
Alan Garber et al.
Endocrine Practice (2015)
Sodium/Glucose Cotransporter 2 Inhibitors and Prevention of Diabetic Nephropathy: Targeting the Renal Tubule in Diabetes
Luca De Nicola et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy
Hala Yamout et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z. I. Cherney et al.
CIRCULATION (2014)
Insulin Degludec: Pharmacokinetics in Patients with Renal Impairment
Istvan Kiss et al.
CLINICAL PHARMACOKINETICS (2014)
OUTCOMES ASSOCIATED WITH NONCONCORDANCE TO NATIONAL KIDNEY FOUNDATION GUIDELINE RECOMMENDATIONS FOR ORAL ANTIDIABETIC DRUG TREATMENTS IN PATIENTS WITH CONCOMITANT TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
Shih-Yin Chen et al.
ENDOCRINE PRACTICE (2014)
Metformin in Patients With Type 2 Diabetes and Kidney Disease A Systematic Review
Silvio E. Inzucchi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
Donald E. Kohan et al.
KIDNEY INTERNATIONAL (2014)
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
Anthony H. Barnett et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Chronic Kidney Disease in Diabetes
Philip McFarlane et al.
CANADIAN JOURNAL OF DIABETES (2013)
Appendix 1: Etiologic Classification of Diabetes Mellitus
Canadian Journal of Diabetes (2013)
Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency
Juan Camilo Arjona Ferreira et al.
DIABETES CARE (2013)
Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment A 1-year, randomized, double-blind, placebo-controlled study
Janet B. McGill et al.
DIABETES CARE (2013)
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
J-F Yale et al.
DIABETES OBESITY & METABOLISM (2013)
Pharmacokinetics of vildagliptin in patients with varying degrees of renal impairment
Yan-Ling He et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Age, Renal Dysfunction, Cardiovascular Disease, and Antihyperglycemic Treatment in Type 2 Diabetes Mellitus: Findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study
Anna Solini et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2013)
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
Vlado Perkovic et al.
KIDNEY INTERNATIONAL (2013)
Experience with Vildagliptin in Patients ≥75 Years with Type 2 Diabetes and Moderate or Severe Renal Impairment
Anja Schweizer et al.
DIABETES THERAPY (2013)
Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?
Felix Kulozik et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2013)
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update Foreword
Michael V. Rocco et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Chronic kidney disease in type 2 diabetes patients in France: Prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes
B. Detournay et al.
DIABETES & METABOLISM (2012)
A Randomized Trial of Two Weight-Based Doses of Insulin Glargine and Glulisine in Hospitalized Subjects With Type 2 Diabetes and Renal Insufficiency
David Baldwin et al.
DIABETES CARE (2012)
One-year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment
W. Kothny et al.
DIABETES OBESITY & METABOLISM (2012)
Metformin therapy in patients with chronic kidney disease
J. K. Duong et al.
DIABETES OBESITY & METABOLISM (2012)
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. E. Inzucchi et al.
DIABETOLOGIA (2012)
Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area
Gabriel Coll-de-Tuero et al.
BMC NEPHROLOGY (2012)
Lower value of glycated haemoglobin relative to glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis
Kenji Shima et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2012)
Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin
David W. Boulton et al.
CLINICAL PHARMACOKINETICS (2011)
Comment on: American Diabetes Association. Standards of medical care in diabetes-2011 (vol 34, pg e53, 2011)
V Basevi et al.
DIABETES CARE (2011)
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
Kasia J. Lipska et al.
DIABETES CARE (2011)
Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin
U. Graefe-Mody et al.
DIABETES OBESITY & METABOLISM (2011)
Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment
M. Nowicki et al.
DIABETES OBESITY & METABOLISM (2011)
Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial
V. Lukashevich et al.
DIABETES OBESITY & METABOLISM (2011)
Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study
M. Nowicki et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?
Helen J. Nye et al.
NEPHRON CLINICAL PRACTICE (2011)
Type 2 Diabetes Mellitus and Renal Impairment in a Large Outpatient Electronic Medical Records Database: Rates of Diagnosis and Antihyperglycemic Medication Dose Adjustment
Juliana L. Meyers et al.
POSTGRADUATE MEDICINE (2011)
Standards of Medical Care in Diabetes-2011 AMERICAN DIABETES ASSOCIATION
DIABETES CARE (2011)
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
Remy Boussageon et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Hemoglobin A1c and Fructosamine for Assessing Glycemic Control in Diabetic Patients With CKD Stages 3 and 4
Harn-Shen Chen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Relationship between Assays of Glycemia in Diabetic Subjects with Advanced Chronic Kidney Disease
Barry I. Freedman et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Metformin Use and Mortality Among Patients With Diabetes and Atherothrombosis
Ronan Roussel et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal Function Clinical recommendations
Anders Frid et al.
DIABETES CARE (2010)
The Effect of Iron and Erythropoietin Treatment on the A1C of Patients With Diabetes and Chronic Kidney Disease
Jen M. Ng et al.
DIABETES CARE (2010)
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
Faramarz Ismail-Beigi et al.
LANCET (2010)
Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide
Lisbeth V. Jacobsen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Antidiabetic Medication Use and Prevalence of Chronic Kidney Disease Among Patients With Type 2 Diabetes Mellitus in the United States
Carol E. Koro et al.
CLINICAL THERAPEUTICS (2009)
A Cross-sectional Survey of Chronic Kidney Disease and Diabetic Kidney Disease in Japanese Type 2 Diabetic Patients at Four Urban Diabetes Clinics
Yuko Watanabe et al.
INTERNAL MEDICINE (2009)
Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system
Jean-Pierre Riveline et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William Duckworth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Insulin therapy in renal disease
Pedro Iglesias et al.
DIABETES OBESITY & METABOLISM (2008)
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
J. C. N. Chan et al.
DIABETES OBESITY & METABOLISM (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of renal impairment on the pharmacokinetics of exenatide
Helle Linnebjerg et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor
Arthur J. Bergman et al.
DIABETES CARE (2007)
Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study
Y. Hayashino et al.
DIABETOLOGIA (2007)
Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice
J. P. New et al.
DIABETIC MEDICINE (2007)
The unrecognized prevalence of chronic kidney disease in diabetes
RJ Middleton et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Performance of the modification of diet in renal disease and Cockcroft-Gault equations health and in chronic kidney in the estimation of GFR in disease
ED Poggio et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Effects of rosiglitazone maleate when added to a sulfonylurea regimen in patients with type 2 diabetes mellitus and mild to moderate renal impairment: A post hoc analysis
A Agrawal et al.
CLINICAL THERAPEUTICS (2003)
Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients
G Biesenbach et al.
DIABETIC MEDICINE (2003)
The pharmacokinetics of pioglitazone in patients with impaired renal function
K Budde et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function
C Hasslacher
DIABETES CARE (2003)
Pharmacokinetics of rosiglitazone in patients with varying degrees of renal insufficiency
MC Chapelsky et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Ronal and metabolic effects of insulin lispro in type 2 diabetic sublects with overt nephropathy
P Ruggenenti et al.
DIABETES CARE (2003)
Pharmacokinetics of nateglinide in renally impaired diabetic patients
D Devineni et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Long-term glycemic control measurements in diabetic patients receiving hemodialysis
MS Joy et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Single- and multiple-dose pharmacokinetics of repaglinide in patients with type 2 diabetes and renal impairment
S Schumacher et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Impact of diabetic nephropathy on pharmacodynamic and pharmacokinetic properties of insulin in type 1 diabetic patients
K Rave et al.
DIABETES CARE (2001)
Pharmacokinetics of repaglinide in subjects with renal impairment
TC Marbury et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
